BNR
Burning Rock Biotech Limited$7.25
LiveJun 18, 2026
Market cap
$7.66M
52w range
3.06 – 41.72
P / E
—
EPS
—
Volume
26.04K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Burning Rock Biotech Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →BNR
7.25-81.66%H 41.09L 7.00MA50 15.81MA200 —Avg vol 24K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.98% | -15.11% | -56.59% | -62.08% | -66.59% | -64.02% | +98.63% | -68.34% | -97.39% | -97.06% | -97.06% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$7.25
380 sh
Bid
$6.81
600 sh
Ask
$7.30
5 sh
Spread
$0.490
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Peers
No peer list available for BNR.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|